Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent TaxesFinished GoodsInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current DebtNotes PayablesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Cirtran (CIRX) Cash & Equivalents (2017 - 2025)

Cirtran (CIRX) has disclosed Cash & Equivalents for 14 consecutive years, with $1210.0 as the latest value for Q1 2025.

  • For the quarter ending Q1 2025, Cash & Equivalents fell 59.61% year-over-year to $1210.0, compared with a TTM value of $1210.0 through Mar 2025, down 59.61%, and an annual FY2022 reading of $18081.0, up 230.43% over the prior year.
  • Cash & Equivalents was $1210.0 for Q1 2025 at Cirtran, down from $2996.0 in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $198891.0 in Q1 2023 and bottomed at $1210.0 in Q1 2025.
  • Average Cash & Equivalents over 5 years is $35333.2, with a median of $20741.5 recorded in 2022.
  • The sharpest move saw Cash & Equivalents skyrocketed 420.96% in 2023, then tumbled 98.49% in 2024.
  • Year by year, Cash & Equivalents stood at $5472.0 in 2021, then skyrocketed by 230.43% to $18081.0 in 2022, then grew by 29.43% to $23402.0 in 2023, then tumbled by 87.2% to $2996.0 in 2024, then tumbled by 59.61% to $1210.0 in 2025.
  • Business Quant data shows Cash & Equivalents for CIRX at $1210.0 in Q1 2025, $2996.0 in Q1 2024, and $23402.0 in Q3 2023.